Cardiology

Journal Club ft. NEJM publications

Questions discussed in this category

Would you recommend that a patient with stable coronary artery disease and well-controlled RA on a JAK inhibitor continue on their current therapy?

2 Answers available

Papers discussed in this category

N Engl J Med,

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.

Related Topics in Cardiology